Urol. praxi. 2021;22(4):185-190 | DOI: 10.36290/uro.2020.049

Uroinfections and increasing bacterial resistance

doc. MUDr. Jozef Marenčák, PhD.
Bratislava

In the past few decades, worldwide prevalence of antimicrobial resistance is increasing at a rapid pace. This is to the extent that development of new antimicrobial drugs is falling short of demand to effectively treat this resistance. Mechanisms behind antimicrobial resistance involve changes to microbial outer membrane, drug efflux pump abnormalities, production of the enzyme beta-lactamase, the creation of biofilms around cell bodies and the like. Incidence of resistance was found to be more in elderly population, male sex and inpatient population. This article describes the current state of resistant microbes associated with urinary tract infections and countermeasures for antimicrobial resistance, including new antimicrobials.

Keywords: urinary tract infection, antimicrobial resistant bacteria, therapy, prevention.

Received: October 8, 2020; Revised: October 8, 2020; Accepted: October 28, 2020; Prepublished online: October 28, 2020; Published: November 24, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marenčák J. Uroinfections and increasing bacterial resistance. Urol. praxi. 2021;22(4):185-190. doi: 10.36290/uro.2020.049.
Download citation

References

  1. Bonkat G, Bartoletti R, Bruyere F, et al. EAU guidelines on urological infections [online]. [cit. 2020-3-25]. Dostupné z: https://uroweb.org/guidelines.
  2. Kot B. Antibiotic resistance among uropathogenic Escherichia coli. Pol J Micobiol. 2019; 68(4): 403-415. Go to original source... Go to PubMed...
  3. Marenčák J. Antibiotiká ako voľba v prevencii infekcií močových ciest. Via Practica 2019; 16(4): 171-176.
  4. Bhatia S. Multidrug resistant urinary tract infection. In: Khera R. Update on urinary tract infection. Jaypee Brothers Medical Publishers Ltd. 2018. Go to original source...
  5. Asadi K, Habibi M, Bouzari S. Urinary tract infection: pathogenicity, antibiotic resistance and development of effective vaccine against uropathogenic Escherichia coli. Mol Immunol 2019; 108(4): 56-67. Go to original source... Go to PubMed...
  6. Mody L, Mehta M. Older men may benefit from antimicrobial prophylaxis for recurrent urinary tract infections. Age and Ageing 2019; 48(1): 167-168. Go to original source... Go to PubMed...
  7. Magistro G, Stief Ch. The urinary tract microbiome: the answer to all our open questions? Eur Urol Focus 2019; 5(1): 36-38. Go to original source... Go to PubMed...
  8. Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic - resistant bacteria and tuberculosis. Lancet Infect Dis 2018; 18: 318-327. Go to original source... Go to PubMed...
  9. Schaeffer A, Matulewicz R, Klumpp D. Infections of the urinary tract. In: Wein A, Kavoussi L, Partin A, et al. Campbell - Walsh Urology. 11th ed. Saunders Elsevier 2016.
  10. Göböová M, Kuželová M. Bakteriálna rezistencia z pohľadu klinického farmaceuta. Praktické lekárnistvo 2013; 3(2): 49-50.
  11. Marenčák J. Aktuálna klasifikácia infekcií močových ciest - časť druhá. Medical Practice 2018; 13(19): 5-8. Go to original source...
  12. Epstein L, Hunter J, Arwady M, et al. New Delhi metallo - β - lactamase - producing carbapenem - resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014; 312(14): 1447-1455. Go to original source... Go to PubMed...
  13. Boyle D, Zembower T. Epidemiology and management of emerging drug resistant gram-negative bacteria: extended spectrum β-lactmases and beyond. Urol Clin North Am 2014; 312(14): 1447-1455.
  14. Kitano H, Teishima J, Shigemura K, et al. Current status of countermeasures for infectious diseases and resistant microbes in the field of urology. Int J Urol 2019; 26(12): 1090-1098. Go to original source... Go to PubMed...
  15. Tamadonfar K, Omattage N, Spaulding C, et al. Reaching the end of the line: urinary tract infection. Microbiol Spectrum 2019; 7(3): BAI-0014-2019. doi:10.1128/microbiolspec. BAI-0014-2019. Go to original source... Go to PubMed...
  16. Ahmed S, Shariq A, Alsaloom A, et al. Uropathogens and their antimicrobial resistance patterns: relationship with urinary tract infections. Int J Health Sci 2019; 13(2): 48-55.
  17. Smart A, Costello B, White P, et al. Sniffing out resistance - rapid identification of urinary tract infection - causing bacteria and their antibiotic susceptibility using volatile metabolites profiles. J Pharm Biomed Anal 2019; 167: 59-65. Go to original source... Go to PubMed...
  18. Ramos N, Dzung D, Stopsack K, et al. Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries. Eur J Clin Microbiol Infect Dis 2011; 30(12): 1587-1593. Go to original source... Go to PubMed...
  19. Kizilca O, Siraneci R, Yilmaz A, et al. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 2012; 54(6): 858-862. Go to original source... Go to PubMed...
  20. Radmayr C, Bogaert G, Dogan H, et al. EAU guidelines on pediatric urology [online]. [cit. 2020-3-25]. Dostupné na: https://uroweb.org/guidelines.
  21. Kutasy B, Coyle D, Fossum M. Urinary tract infection in children: management in the era of antibiotic resistance - a pediatric urologist´s view. Eur Urol Focus 2017; 3(2-3): 207-213. Go to original source... Go to PubMed...
  22. Kurt-Sükür E, Özcakar Z, Dogan Ö, et al. The changing resistance patterns of bacterial uropathogens in children. Pediatr Int 2020; 144: 104196. doi: 10.1016/j.micpath.2020.104196 [Epub ahead of print]. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.